The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Structure, membrane orientation, mechanism, and function of pexiganan — A highly potent antimicrobial peptide designed from magainin
Open accessAbstract
The growing problem of bacterial resistance to conventional antibiotic compounds and the need for new antibiotics has stimulated interest in the development of antimicrobial peptides (AMPs) as human therapeutics. Development of topically applied agents, such as pexiganan (also known as MSI-78, an analog of the naturally occurring magainin2, extracted from the skin of the African frog Xenopus laevis) has been the focus of pharmaceutical development largely because of the relative safety of topical therapy and the uncertainty surrounding the long-term toxicology of any new class of drug administered systemically. The main hurdle that has hindered the development of antimicrobial peptides is that many of the naturally occurring peptides (such as magainin), although active in vitro, are effective in animal models of infection only at very high doses, often close to the toxic doses of the peptide, reflecting an unacceptable margin of safety. Though MSI-78 did not pass the FDA approval, it is still the best-studied AMP to date for therapeutic purposes. Biophysical studies have shown that this peptide is unstructured in solution, forms an antiparallel dimer of amphipathic helices upon binding to the membrane, and disrupts membrane via toroidal-type pore formation. This article covers functional, biophysical, biochemical and structural studies on pexiganan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 1×
“Later, reports of reduced susceptibility to vancomycin were made in 1997 [4] followed by isolation of vancomycin resistant S.”
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
"Celbenin" - resistant Staphylococci
Jevons, M. P. (1961) · BMJ · doi:10.1136/bmj.1.5219.124-a · Cited by 1,680
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Defensins. Natural peptide antibiotics of human neutrophils.
Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112120 · Cited by 1,416
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Self-citationAmphipathic, α-helical antimicrobial peptides
Tossi, A., Sandri, L., & Giangaspero, A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<4::aid-bip30>3.0.co;2-m · Cited by 1,247
The role of cationic antimicrobial peptides in innate host defences
Hancock, R. E. W., & Diamond, G. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01823-0 · Cited by 1,218
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Self-citationTryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.04.006 · Cited by 1,039
Mode of action of linear amphipathic α-helical antimicrobial peptides
Oren, Z., & Shai, Y. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<451::aid-bip4>3.0.co;2-f · Cited by 848
Bals, R., Wang, X., Zasloff, M., & Wilson, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9541 · Cited by 746
Wu, M., Maier, E., Benz, R., & Hancock, R. E. W. (1999) · Biochemistry · doi:10.1021/bi9826299 · Cited by 736
Matsuzaki, K., Murase, O., Fujii, N., & Miyajima, K. (1996) · Biochemistry · doi:10.1021/bi960016v · Cited by 723
Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., & Barron, A. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708254105 · Cited by 657
Giangaspero, A., Sandri, L., & Tossi, A. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2001.02494.x · Cited by 636
Detergent-like actions of linear amphipathic cationic antimicrobial peptides
Bechinger, B., & Lohner, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.001 · Cited by 593
Magainins as paradigm for the mode of action of pore forming polypeptides
Matsuzaki, K. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00014-8 · Cited by 589
Bevins, C. L., & Zasloff, M. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.002143 · Cited by 585
Rotational-echo double-resonance NMR
Gullion, T., & Schaefer, J. (2011) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2011.09.003 · Cited by 548
Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils.
Selsted, M. E., Novotny, M. J., Morris, W. L., Tang, Y. Q., Smith, W., & Cullor, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42830-x · Cited by 546
Nakamura, T., Furunaka, H., Miyata, T., Tokunaga, F., Muta, T., Iwanaga, S., Niwa, M., Takao, T., & Shimonishi, Y. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37448-9 · Cited by 531
Mechanism of Lipid Bilayer Disruption by the Human Antimicrobial Peptide, LL-37
Henzler Wildman, K. A., Lee, D.-K., & Ramamoorthy, A. (2003) · Biochemistry · doi:10.1021/bi0273563 · Cited by 518
Self-citationHost defense peptides as new weapons in cancer treatment
Papo, N., & Shai, Y. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4560-2 · Cited by 501
Structure–activity studies on magainins and other host defense peptides
Maloy, W. L., & Kari, U. P. (1995) · Biopolymers · doi:10.1002/bip.360370206 · Cited by 490
Relationship of Membrane Curvature to the Formation of Pores by Magainin 2
Matsuzaki, K., Sugishita, K.-I., Ishibe, N., Ueha, M., Nakata, S., Miyajima, K., & Epand, R. M. (1998) · Biochemistry · doi:10.1021/bi980539y · Cited by 452
Zelezetsky, I., & Tossi, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.021 · Cited by 439
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin.
Lee, J. Y., Boman, A., Sun, C. X., Andersson, M., Jörnvall, H., Mutt, V, & Boman, H. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9159 · Cited by 435
Molecular Basis for Membrane Selectivity of an Antimicrobial Peptide, Magainin 2
Matsuzaki, K., Sugishita, K., Fujii, N., & Miyajima, K. (1995) · Biochemistry · doi:10.1021/bi00010a034 · Cited by 419
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity
Oppenheim, J. J., Biragyn, A., Kwak, L. W., & Yang, D. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii17 · Cited by 407
Mimicry of Host-Defense Peptides by Unnatural Oligomers: Antimicrobial β-Peptides
Porter, E. A., Weisblum, B., & Gellman, S. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0260871 · Cited by 379
Antimicrobial activity of synthetic magainin peptides and several analogues.
Zasloff, M., Martin, B., & Chen, H. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.910 · Cited by 373
Hallock, K. J., Lee, D.-K., & Ramamoorthy, A. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)70031-9 · Cited by 371
Self-citationPichichero, M. E., & Casey, J. R. (2007) · JAMA · doi:10.1001/jama.298.15.1772 · Cited by 367
Matsuzaki, K., Sugishita, K.-I., Harada, M., Fujii, N., & Miyajima, K. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00051-5 · Cited by 363
In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin
Ge, Y., MacDonald, D. L., Holroyd, K. J., Thornsberry, C., Wexler, H., & Zasloff, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.782 · Cited by 359
Bechinger, B., Zasloff, M., & Opella, S. J. (1993) · Protein Science · doi:10.1002/pro.5560021208 · Cited by 357
The human beta-defensin-3, an antibacterial peptide with multiple biological functions
Dhople, V., Krukemeyer, A., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.007 · Cited by 355
Self-citationAGERBERTH, B., LEE, J., BERGMAN, T., CARLQUIST, M., BOMAN, H. G., MUTT, V., & JÖRNVALL, H. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16442.x · Cited by 348
Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H., & Nagaoka, I. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1066::aid-immu1066>3.0.co;2-# · Cited by 347
Molecular Mechanism of Peptide-Induced Pores in Membranes
Huang, H. W., Chen, F.-Y., & Lee, M.-T. (2004) · Physical Review Letters · doi:10.1103/physrevlett.92.198304 · Cited by 336
The Role of Antimicrobial Peptides in Innate Immunity
Ganz, T. (2003) · Integrative and Comparative Biology · doi:10.1093/icb/43.2.300 · Cited by 320
Mechanisms for induction of acquired host immunity by neutrophil peptide defensins
Lillard, J. W., Boyaka, P. N., Chertov, O., Oppenheim, J. J., & McGhee, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.651 · Cited by 305
Perturbation of the Hydrophobic Core of Lipid Bilayers by the Human Antimicrobial Peptide LL-37
Henzler-Wildman, K. A., Martinez, G. V., Brown, M. F., & Ramamoorthy, A. (2004) · Biochemistry · doi:10.1021/bi036284s · Cited by 296
Self-citationMagainins and the disruption of membrane-linked free-energy transduction.
Westerhoff, H. V., Juretić, D., Hendler, R. W., & Zasloff, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6597 · Cited by 290
Synthetic magainin analogues with improved antimicrobial activity
Chen, H., Brown, J. H., Morell, J. L., & Huang, C. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80077-2 · Cited by 280
Ramamoorthy, A., Thennarasu, S., Lee, D.-K., Tan, A., & Maloy, L. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.073890 · Cited by 273
Self-citationImproved antimicrobial peptides based on acyl-lysine oligomers
Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007) · Nature Biotechnology · doi:10.1038/nbt1309 · Cited by 256
Antimicrobial Activity and Protease Stability of Peptides Containing Fluorinated Amino Acids
Meng, H., & Kumar, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075373f · Cited by 252
Johnson, A. P. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.143 · Cited by 247
Anticancer efficacy of Magainin2 and analogue peptides.
Baker, M. A., Maloy, W. L., Zasloff, M., & Jacob, L. S. (1993) · PubMed · Cited by 236
Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones
Giovannini, M. G., Poulter, L., Gibson, B. W., & Williams, D. H. (1987) · Biochemical Journal · doi:10.1042/bj2430113 · Cited by 217
Mecke, A., Lee, D.-K., Ramamoorthy, A., Orr, B. G., & Banaszak Holl, M. M. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.062596 · Cited by 216
Self-citationMembrane Composition Determines Pardaxin's Mechanism of Lipid Bilayer Disruption
Hallock, K. J., Lee, D.-K., Omnaas, J., Mosberg, H. I., & Ramamoorthy, A. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75226-0 · Cited by 207
Self-citationTani, K., Murphy, W. J., Chertov, O., Salcedo, R., Koh, C. Y., Utsunomiya, I., Funakoshi, S., Asai, O., Herrmann, S. H., Wang, J. M., et al. (2000) · International Immunology · doi:10.1093/intimm/12.5.691 · Cited by 203
Porcelli, F., Verardi, R., Shi, L., Henzler-Wildman, K. A., Ramamoorthy, A., & Veglia, G. (2008) · Biochemistry · doi:10.1021/bi702036s · Cited by 189
Self-citationPISEMA Solid-State NMR Spectroscopy
(2004) · Annual Reports on NMR Spectroscopy · doi:10.1016/s0066-4103(04)52001-x · Cited by 186
Papo, N., & Shai, Y. (2003) · Biochemistry · doi:10.1021/bi027212o · Cited by 174
Action mechanism of tachyplesin I and effects of PEGylation
Imura, Y., Nishida, M., Ogawa, Y., Takakura, Y., & Matsuzaki, K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.005 · Cited by 173
Porcelli, F., Buck-Koehntop, B. A., Thennarasu, S., Ramamoorthy, A., & Veglia, G. (2006) · Biochemistry · doi:10.1021/bi0601813 · Cited by 168
Self-citationAmphiphilic α-Helical Antimicrobial Peptides and Their Structure / Function Relationships
Dennison, S., Wallace, J., Harris, F., & Phoenix, D. (2005) · Protein & Peptide Letters · doi:10.2174/0929866053406084 · Cited by 161
Antibacterial and Hemolytic Activities of Quaternary Pyridinium Functionalized Polynorbornenes
Eren, T., Som, A., Rennie, J. R., Nelson, C. F., Urgina, Y., Nüsslein, K., Coughlin, E. B., & Tew, G. N. (2008) · Macromolecular Chemistry and Physics · doi:10.1002/macp.200700418 · Cited by 160
Cooperative membrane insertion of magainin correlated with its cytolytic activity
Ludtke, S. J., He, K., Wu, Y., & Huang, H. W. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90050-7 · Cited by 153
Glaser, R. W., Sachse, C., Dürr, U., Wadhwani, P., Afonin, S., Strandberg, E., & Ulrich, A. S. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.056424 · Cited by 151
Raman spectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa
Williams, R. W., Starman, R., Taylor, K. M. P., Gable, K. S., Beeler, T., ZASLOFF, M. A., & Covell, D. G. (1990) · Biochemistry · doi:10.1021/bi00470a031 · Cited by 144
From Innate Immunity to de-Novo Designed Antimicrobial Peptides
Shai, Y. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023395367 · Cited by 144
Harwig, S. S. L., Waring, A. J., Yang, H. J., Cho, Y., Tan, L., & Lehrer, R. I. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0352h.x · Cited by 139
Papo, N., Seger, D., Makovitzki, A., Kalchenko, V., Eshhar, Z., Degani, H., & Shai, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4569 · Cited by 139
Chemoattractant properties of PR-39, a neutrophil antibacterial peptide
Huang, H.-J., Ross, C. R., & Blecha, F. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.5.624 · Cited by 135
Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A
Thennarasu, S., Lee, D.-K., Poon, A., Kawulka, K. E., Vederas, J. C., & Ramamoorthy, A. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2005.06.003 · Cited by 134
Self-citationRamamoorthy, A., Thennarasu, S., Tan, A., Gottipati, K. K., Sreekumar, S., Heyl, D., An, F. Y., & Shelburne, C. E. (2006) · Biochemistry · doi:10.1021/bi052629q · Cited by 125
Self-citationLamb, H. M., & Wiseman, L. R. (1998) · Drugs · doi:10.2165/00003495-199856060-00011 · Cited by 108
Synergistic Transmembrane Alignment of the Antimicrobial Heterodimer PGLa/Magainin
Tremouilhac, P., Strandberg, E., Wadhwani, P., & Ulrich, A. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604759200 · Cited by 107
Kulkarni, M., McMaster, W. R., Kamysz, E., Kamysz, W., Engman, D. M., & McGwire, B. S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05459.x · Cited by 107
Tremouilhac, P., Strandberg, E., Wadhwani, P., & Ulrich, A. S. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.029 · Cited by 100
Effects of Acyl versus Aminoacyl Conjugation on the Properties of Antimicrobial Peptides
Radzishevsky, I. S., Rotem, S., Zaknoon, F., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2412-2420.2005 · Cited by 98
Rugeles, M. T., Trubey, C. M., Bedoya, V. I., Pinto, L. A., Oppenheim, J. J., Rybak, S. M., & Shearer, G. M. (2003) · AIDS · doi:10.1097/00002030-200303070-00002 · Cited by 97
Gottler, L. M., de la Salud‐Bea, R., Shelburne, C. E., Ramamoorthy, A., & Marsh, E. N. G. (2008) · Biochemistry · doi:10.1021/bi801045n · Cited by 90
Self-citationIn Vitro Antimicrobial Activity of MSI-78, a Magainin Analog
FUCHS, P. C., Barry, A. L., & Brown, S. D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1213 · Cited by 86
The big and small of drug discovery
Moore, A. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor748 · Cited by 54
Powers, J.-P. S., Martin, M. M., Goosney, D. L., & Hancock, R. E. W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1522-1524.2006 · Cited by 51
Giacometti, A., Cirioni, O., Kamysz, W., D’Amato, G., Silvestri, C., Licci, A., Nadolski, P., Riva, A., Łukasiak, J., & Scalise, G. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.06.011 · Cited by 30
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock
Giacometti, A., Cirioni, O., Ghiselli, R., Orlando, F., Kamysz, W., Rocchi, M., D’Amato, G., Mocchegiani, F., Silvestri, C., Łukasiak, J., et al. (2004) · Peptides · doi:10.1016/j.peptides.2004.09.012 · Cited by 25
Membrane Lipid Composition and the Interaction of Pardaxin: The Role of Cholesterol
Epand, R. F., Ramamoorthy, A., & Epand, R. M. (2006) · Protein and Peptide Letters · doi:10.2174/092986606774502063 · Cited by 5
Self-citation
Cited by
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Prevention of Intravascular Catheter-Related Infections
(2021) · Indian Journal of Continuing Nursing Education · doi:10.4103/2230-7354.320831 · Cited by 855
Ageitos, J. M., Sánchez-Pérez, A., Calo-Mata, P., & Villa, T. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.018 · Cited by 614
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Metadata
- Authors
- Gottler, L. M., & Ramamoorthy, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 1788
- Issue
- 8
- Pages
- 1680-1686
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2123172081
- Cited by
- 354
- References
- 90
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.